Smith Patrick W's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Feb 11, 2025
- Accession no.
- 0001493152-25-005942
- Filed
- Feb 11, 2025
- Trade date
- Feb 7, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $2.21M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Patrick WCIK 0001167028 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | Common Stock, no par value | PPurchaseAcquired | +1,077,600 | $2.05 | +$2,209,080 | 2,872,671 | Indirect | |
| Feb 7, 2025 | Common Stock, no par value | JOtherAcquired | +385,814 | $2.05 | +$790,918.7 | 3,258,485 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.